Recent News

  • Novation awards Genelex Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine SoftwareIRVING, TEXAS; Aug. 4, 2015 – Novation, the nation’s largest healthcare services organization, has awarded  an agreement to Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and other healthcare providers improve patient care and reduce health care costs. Annually, more than 8.6 million ...Read More
  • FDA strengthens heart attack, stroke risk warnings for NSAID pain medicationsPeople regularly taking a common type of painkiller called an NSAID may be at greater risk for heart attack or stroke than previously thought. The U.S. Food and Drug Administration (FDA) has strengthened existing warnings of potentially deadly heart attack and stroke risk for a class of pain medications known ...Read More